Surgical Science Sweden AB (publ) / Fundamentals
Income statement
- Net revenue
€86.41M - Cost of goods sold
€27.77M - Gross profit
€58.64M - SG&A expenses
€26.07M - R&D expenses
€19.20M - EBITDA
€11.47M - D&A
€2.89M - EBIT
€7.92M - Interest expenses
€0.00 - EBT
€10.99M - Tax expenses
€2.52M - Net income
€8.47M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€2.46M - Changes in working capital
-€4.47M - Operating cash flow
€8.25M - Capex
€4.39M - Other investing cash flow
-€3.80M - Net investing cash flow
-€12.17M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€21.57M - Other financing cash flow
€21.46M - Net financing cash flow
-€102.78K - Foreign exchange effects
-€1.18M - Net change in cash
-€5.21M - Cash at end of period
€55.90M - Free cash flow
€12.64M
Balance sheet
- Cash and cash equivalents
€55.90M - Cash and short-term investments
€55.90M - Total receivables
€25.95M - Inventory
€18.92M - Other current assets
-€91.61 - Total current assets
€100.77M - Property, plant & equipment
€9.86M - Goodwill
€290.63M - Intangible assets
€28.50M - Long-term investments
€772.44K - Other non-current assets
€0.00 - Total non-current assets
€331.05M - Total assets
€431.81M - Accounts payable
€0.00 - Short-term debt
€0.00 - Other current liabilities
€24.67M - Total current liabilities
€24.67M - Long-term debt
€150.60K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€12.40M - Total non-current liabilities
€12.55M - Total liabilities
€37.22M - Common stock
€233.69K - Retained earnings
€59.78M - Other equity
€23.29M - Total equity
€394.60M - Total liabilities and shareholders' equity
€431.81M
Company information
- Market capitalization
€712.85M - Employees
274 - Enterprise Value
€7.51B
Company ratios
- Gross margin
-
67.9% Better than peer group: 59.4% - EBITDA margin
-
13.3% Much better than peer group: -41.2% - EBIT margin
-
9.2% Much better than peer group: -52.7% - EBT margin
-
12.7% Much better than peer group: -55.0% - Net margin
-
9.8% Much better than peer group: -66.4% - ROE
-
2.1% Much better than peer group: -14,682.0% - ROA
-
2.0% Much better than peer group: -9,601.8% - Asset turnover
-
20.0% Much worse than peer group: 1,207,392.8% - FCF margin
-
4.5% Much better than peer group: -51.0% - FCF yield
0.5% - Efficiency ratio
86.7% - Net sales per employee
-
€315.36K - Net income per employee
-
€30.91K